Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00984425 | The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors | completed | Phase 1 | 30 | Istituto Clinico HumanitasOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT00305799 | Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors | completed | — | 59 | Case Comprehensive Cancer CenterOTHER | 1 | Nov 24, 2014 | clinicaltrials |
| NCT00276575 | Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 65 | Herbert Hurwitz, MDOTHER | 1 | Nov 19, 2014 | clinicaltrials |
| NCT00586443 | BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)(BEP) | completed | Phase 1 | 56 | Herbert Hurwitz, MDOTHER | 1 | Nov 19, 2014 | clinicaltrials |
| NCT00667147 | Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib | completed | Phase 1 | 65 | University of Southern CaliforniaOTHER | 1 | Nov 19, 2014 | clinicaltrials |
| NCT01165385 | Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid Tumors(PACIFIK) | completed | Phase 1 | 35 | UNICANCEROTHER | 1 | Nov 17, 2014 | clinicaltrials |
| NCT01238939 | Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer | completed | Phase 1 | 35 | Nippon Kayaku Co., Ltd.INDUSTRY | 1 | Nov 13, 2014 | clinicaltrials |
| NCT01238952 | Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer | completed | Phase 1 | 4 | Nippon Kayaku Co., Ltd.INDUSTRY | 1 | Nov 13, 2014 | clinicaltrials |
| NCT01158274 | RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 2 | Nov 7, 2014 | clinicaltrials |
| NCT00914914 | Safety Study of a Cell Penetrating Peptide (p28) to Treat Solid Tumors That Resist Standard Methods of Treatment | completed | Phase 1 | 15 | Dr. Tapas K. Das GuptaINDUSTRY | 1 | Oct 28, 2014 | clinicaltrials |
| NCT01164163 | INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease | completed | Phase 1 | 49 | Children's Oncology GroupNETWORK | 1 | Oct 23, 2014 | clinicaltrials |
| NCT01245205 | Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer | completed | Phase 1 | 28 | National Cancer Institute (NCI)NIH | 1 | Oct 23, 2014 | clinicaltrials |
| NCT01567163 | A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors | completed | Phase 2 | 22 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 16, 2014 | clinicaltrials |
| NCT00357500 | Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer | completed | Phase 2 | 101 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 1, 2014 | clinicaltrials |
| NCT01992341 | AMG 386 Drug-Drug Interaction Study With Paclitaxel | completed | Phase 1 | 35 | AmgenINDUSTRY | 1 | Sep 23, 2014 | clinicaltrials |
| NCT00968916 | Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 in Patients With Solid Tumors | completed | Phase 1 | 15 | SanofiINDUSTRY | 1 | Sep 19, 2014 | clinicaltrials |
| NCT01279603 | Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors Including Lymphomas | completed | Phase 1 | 23 | Genus Oncology, LLCINDUSTRY | 1 | Sep 19, 2014 | clinicaltrials |
| NCT00687934 | Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors | completed | Phase 1 | 53 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Sep 18, 2014 | clinicaltrials |
| NCT00004258 | EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer | completed | Phase 1 | 40 | Indiana UniversityOTHER | 1 | Sep 17, 2014 | clinicaltrials |
| NCT01702129 | Anti-EGFR Immunoliposomes in Solid Tumors | completed | Phase 1 | 26 | University Hospital, Basel, SwitzerlandOTHER | 1 | Sep 9, 2014 | clinicaltrials |
| NCT00057915 | Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer | completed | Phase 1 | 4 | Duke UniversityOTHER | 1 | Sep 8, 2014 | clinicaltrials |
| NCT00275080 | Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Aug 27, 2014 | clinicaltrials |
| NCT00720148 | A Phase I Trial of Bortezomib and Sunitinib | completed | Phase 1 | 30 | Emory UniversityOTHER | 1 | Aug 26, 2014 | clinicaltrials |
| NCT01008930 | Feasibility Study for Imaging of Peripheral Tumors With a High-Resolution PET Imaging System | completed | N/A | 19 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 20, 2014 | clinicaltrials |
| NCT01392976 | Safety and Pharmacokinetic Profiles of Two Formulations of CO-1.01 in Patients With Advanced Solid Tumors | completed | Phase 1 | 17 | Clovis Oncology, Inc.INDUSTRY | 1 | Aug 15, 2014 | clinicaltrials |
| NCT01313065 | Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors | completed | Phase 1 | 42 | Vaccinex Inc.INDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
| NCT01974349 | To Assess the Effect of Food on the Pharmacokinetics of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Male Volunteers | completed | Phase 1 | 39 | AstraZenecaINDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
| NCT00003750 | Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors | completed | Phase 1 | 28 | Children's Oncology GroupNETWORK | 3 | Aug 8, 2014 | clinicaltrials |
| NCT01215864 | Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors | completed | Phase 1 | 28 | Traslational Cancer Drugs Pharma, SLINDUSTRY | 1 | Aug 8, 2014 | clinicaltrials |
| NCT00107458 | Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors | completed | Phase 1 | 26 | Children's Oncology GroupNETWORK | 2 | Aug 7, 2014 | clinicaltrials |
| NCT00003070 | Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer | completed | Phase 3 | 13 | Children's Oncology GroupNETWORK | 3 | Aug 5, 2014 | clinicaltrials |
| NCT00002621 | Interferon Alfa in Treating Children With HIV-Related Cancer | completed | Phase 2 | 8 | Children's Oncology GroupNETWORK | 4 | Jul 24, 2014 | clinicaltrials |
| NCT00567931 | 1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery | completed | Phase 1 | 52 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2014 | clinicaltrials |
| NCT01191216 | 1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2014 | clinicaltrials |
| NCT00847054 | A Study of of MORAb-004 in Subjects With Solid Tumors | completed | Phase 1 | 80 | MorphotekINDUSTRY | 1 | Jul 16, 2014 | clinicaltrials |
| NCT00909207 | Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing | completed | — | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 14, 2014 | clinicaltrials |
| NCT00759928 | PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid Tumors | completed | Phase 1 | 48 | SCRI Development Innovations, LLCOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT01222546 | Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | Chugai Pharma Europe Ltd.INDUSTRY | 1 | Jun 23, 2014 | clinicaltrials |
| NCT00408655 | Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2014 | clinicaltrials |
| NCT00609141 | IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor | completed | Phase 1 | 34 | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2014 | clinicaltrials |
| NCT01005355 | Study of IMC-1121B in Patients With Advanced Solid Tumors | completed | Phase 1 | 15 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 18, 2014 | clinicaltrials |
| NCT00058253 | Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2014 | clinicaltrials |
| NCT00121264 | 17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2014 | clinicaltrials |
| NCT00217412 | Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2014 | clinicaltrials |
| NCT00104962 | Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT01401504 | Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors | completed | Phase 1 | 29 | Astellas Pharma IncINDUSTRY | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00918281 | Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection | completed | Phase 2 | 70 | GE HealthcareINDUSTRY | 1 | Jun 9, 2014 | clinicaltrials |
| NCT00706290 | Brief CBT for Anxiety and Advanced Cancer | completed | Phase 2 | 49 | Massachusetts General HospitalOTHER | 1 | Jun 6, 2014 | clinicaltrials |
| NCT00580034 | Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath | completed | Phase 2 | 176 | David Rizzieri, MDOTHER | 1 | Jun 3, 2014 | clinicaltrials |
| NCT00483093 | Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor | completed | Phase 1 | 22 | AGC Biologics S.p.A.INDUSTRY | 1 | May 30, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Dec 2, 2014source: clinicaltrials